Breaking News

Aesica Implements Serialization Solution to Meet CFDA Changes

June 23, 2014

New requirements cut serialization deadline to three months

Aesica Pharmaceuticals S.r.l, the Italian division of Aesica, has launched a QAD integrated serialization system to comply with new requirements from China’s Food and Drug Administration (CFDA) at its site in Pianezza, which cut the serialization implementation deadline to three months from the previous 12 month timeline. In partnership with QAD, a provider of enterprise software solutions, Aesica implemented the serialization solution for two pharmaceutical products for the Chinese market.
 
The new serialization solution allows Aesica to identify individual packaging down to the smallest sellable unit sizes and individual unit serial numbers as packages are bundled, boxed and placed on shipping pallets. Aesica Pianezza can track and trace each single pack of medication and report serial numbers to the required Government Agencies for a small number of products once produced and imported.
 
Maurizio Beninati, IT manager Italy at Aesica Pharmaceuticals said, “Major changes are happening in product serialization and tracking regulations across pharmaceutical markets worldwide and China is a prime example of this. The ability to respond swiftly to adjust practices and processes to meet these challenges head on is pivotal to success in this fiercely competitive environment. QAD has proven to be a great strategic partner in the rush to meet such a hugely accelerated deadline from the CFDA. By combining our respective skills and expertise, we conquered this challenge in full.”

Related Packaging:

Related Contract Manufacturing:

blog comments powered by Disqus
  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors

  • Platinum Press Facility Tour

    Platinum Press Facility Tour

    Kristin Brooks, Contract Pharma||March 23, 2016
    Opens doors to new, 47,000-sq.-ft. packaging facility in Oakland, NJ

  • Biopharma Packaging Equipment Close-up

    Biopharma Packaging Equipment Close-up

    Kristin Brooks, Contract Pharma||March 7, 2016
    Sieghard Schuchmann of OPTIMA discusses biopharma trends impacting packaging equipment, and the latest capabilities

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Getting Real

    Michael Pollock, PPD||November 17, 2015
    Partnering for clinical and real-world evidence studies

  • Bringing Transparency and Collaboration to CRO Oversight

    Bringing Transparency and Collaboration to CRO Oversight

    Craig Morgan , goBalto Inc. ||November 17, 2015
    Relationships between sponsors and CROs are getting stronger